Answerthink (ANSR) Announces Strategic Alliance with LORENZ Life Sciences Group
More News related to ANSR
- Insight Direct Appoints New CEO and CFO to Accelerate Strategic Growth
- Answerthink (ANSR) Is Up Over 30% Today; Firm Raises Price Target
- answerthink (ANSR) Reports Third Quarter Earnings; Guides Q4
- Answerthink (ANSR) Raises Buyback By $5M
- answerthink (ANSR) Reports Q2 EPS of $0.04
More News related to FDA
- Mangers of Bear Stearns Hedge Fund Collapse Acquitted
- ex-Bear Stearn Hedge Fund Managers Cioffi and Tannin Acquitted
- Oil Drops on Weakened Tropical Storm Ida Outlook (USO, OIL, OIH, DIG)
- Priceline.com (PCLN) Earnings Boost Other Sector Stocks Up (OWW, EXPE, TZOO)
- Dow Surges 200 Points As G-20 Promises To Keep The Pump Primed
Answerthink, Inc. (NASDAQ: ANSR) has formed a strategic alliance with LORENZ Life Sciences Group for the distribution of LORENZ solutions in North America. Answerthink and LORENZ Life Sciences Group will serve midsize companies by integrating best practice submissions management solutions into Answerthink\'s Life Science solutions based on SAP technology.
Answerthink\'s pre-configured EzLifeSciences solutions are designed specifically to help midsize companies streamline new product development, automate manufacture reporting, and meet regulatory compliance requirements. LORENZ\'s solutions are geared specifically for submission assembly, review, publishing, validation and management for regulated environments within the life sciences industry as well as supporting the FDA mandate to submit electronically by the end of 2007.
Related Categories
FDAStocks Mentioned
-0.14Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
